Every material Form 8-K Nordson has filed with the SEC since June 24, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Nordson announced on October 23, 2026 that its subsidiary Nordson London Limited completed its purchase of Contrinex Holding SA, a Swiss manufacturer of position and measurement sensors, for an enterprise value of approximately $168 million. Contrinex generates approximately $50 million in annual revenue and will be integrated into Nordson's Advanced Technology Solutions segment, which the company says adds to its factory automation and control offerings.
Acquisition completed October 23, 2026, under a Share Purchase Agreement dated the same day with seller Annette Heimlicher
Enterprise value of approximately $168 million USD
Contrinex generates approximately $50 million in annual revenue and has nearly 500 employees
Contrinex will be integrated into the Advanced Technology Solutions segment
Nordson reported record fiscal third-quarter 2026 sales of $818 million, up 10% year over year, and diluted EPS of $2.73, up 23%. The company raised its full-year guidance for sales and adjusted earnings, citing backlog up 35% over the prior year.
Q3 net income was $153 million, or $2.73 per diluted share, versus $126 million, or $2.22, a year earlier
Q3 adjusted EPS was a record $3.25, up 19%, excluding a non-cash loss on a minority investment and acquisition-related items
Full-year sales guidance now $3,035 million to $3,075 million; adjusted EPS guidance now $11.80 to $12.00
Management will discuss results on a webcast on August 20, 2026 at 8:30 a.m. Eastern
Nordson reported fiscal second quarter 2026 sales of $741 million, up 8% from a year earlier, with diluted EPS of $2.09 and adjusted diluted EPS of $2.86, up 18%. The company raised its full-year guidance to sales of $2,930 million to $3,010 million and adjusted EPS of $11.30 to $11.80, citing backlog up 18%. GAAP results include a $24 million non-cash pension settlement charge.
Second quarter sales of $741 million vs. $683 million a year earlier; organic sales rose 7%
Net income of $117 million, or $2.09 per diluted share, vs. $1.97 a year earlier
Adjusted EPS of $2.86 vs. $2.42, excluding a $24 million pension settlement charge and other items
Third quarter sales guidance of $760 million to $790 million and adjusted EPS of $2.95 to $3.15; webcast on May 21, 2026 at 8:30 a.m. ET
Nordson reported record first quarter fiscal 2026 sales of $669 million, up 9% year over year, and diluted EPS of $2.38, up 44%, which includes a non-cash gain on a minority investment. The company raised its full-year guidance for sales and adjusted earnings, citing a strong start to the year and a 4% increase in backlog.
Q1 sales $669 million vs. $615 million a year earlier; organic growth 6.5%
Q1 adjusted diluted EPS $2.37, a first quarter record, up 15% from $2.06; GAAP diluted EPS $2.38 vs. $1.65
Full-year fiscal 2026 sales guidance raised to $2,860 million to $2,980 million; adjusted EPS guidance raised to $11.00 to $11.60
Q2 fiscal 2026 sales outlook of $710 million to $740 million and adjusted EPS of $2.70 to $2.90; management webcast February 19, 2026 at 8:30 a.m. ET
Nordson signed an amended and restated credit agreement on January 30, 2026, creating a $1.2 billion senior unsecured multicurrency revolving credit facility that matures January 30, 2031. The company used proceeds to repay and retire $248.0 million of term loans under its prior credit facility.
Facility size: $1,200 million senior unsecured multicurrency revolving credit, maturing January 30, 2031
Sub-limits include $85 million for standby letters of credit, $100 million for swingline loans, and the equivalent of $425 million for certain multicurrency borrowings
Proceeds may fund working capital, acquisitions and general corporate purposes, including refinancing existing debt
Nordson used $248.0 million of proceeds to repay and retire term loans under its prior credit facility
Nordson reported fourth-quarter and fiscal 2025 results, with sales of $752 million (up 1%) and GAAP diluted EPS of $2.69 versus $2.12 a year earlier. The company also issued fiscal 2026 guidance of $2.83 billion to $2.95 billion in sales and adjusted EPS of $10.80 to $11.50, and will discuss the results on a webcast on December 11, 2025.
Q4 fiscal 2025 adjusted EPS was $3.03, up 9% from $2.78; GAAP diluted EPS was $2.69 versus $2.12
Full-year fiscal 2025 sales were a record $2.8 billion, up 4%, with adjusted EPS of $10.24, up 5%
Fiscal 2026 guidance: sales of $2,830 million to $2,950 million and adjusted EPS of $10.80 to $11.50 per diluted share
Management will provide additional commentary on the results and outlook at a webcast on Thursday, December 11, 2025, at 8:30 a.m. ET
Nordson's Compensation Committee adopted an Executive Severance Policy on October 23, 2025, effective November 1, 2025. The policy covers U.S.-based executive officers for qualifying terminations outside the two-year period after a change in control, and it provides a lump-sum payment equal to annual base salary along with other benefits. The filing does not state a dollar cost to the company beyond the $10,000 outplacement cap per executive.
Policy adopted October 23, 2025 and effective November 1, 2025
Lump-sum cash payment equal to the executive's annual base salary, plus a pro-rated annual bonus based on actual full-year performance
Company-paid employer share of medical, dental, and vision coverage for up to 12 months, and outplacement services capped at $10,000
CEO Sundaram Nagarajan is excluded because his employment agreement already provides severance pay outside a change-in-control period
Nordson reported fiscal third-quarter 2025 sales of $742 million, up 12% from a year earlier, and diluted EPS of $2.22 versus $2.04, with adjusted EPS up 13% to $2.73. The company affirmed its full-year guidance, though sales are now tracking slightly below the midpoint and adjusted EPS slightly above it. The board also approved a $500 million share repurchase, bringing total authorization to about $793 million.
Third-quarter sales were $742 million, up from $662 million; organic sales rose 2%, acquisitions added 8%, and currency added 2%.
Diluted EPS was $2.22 versus $2.04; adjusted diluted EPS was $2.73 versus $2.41, up 13%.
Backlog fell about 5% sequentially; full-year sales are tracking slightly below and adjusted EPS slightly above the midpoint of original guidance.
On August 18, 2025, the board authorized an additional $500 million in repurchases; total authorization is about $793 million, including about $293 million previously remaining.
Nordson Corporation appointed Joseph M. Rutledge as Vice President and Chief Accounting Officer on July 14, 2025, making him the principal accounting officer over accounting and financial reporting. The filing says Stephen Shamrock stopped serving in that role and left the company on July 10, 2025. The change concerns the finance leadership that oversees Nordson's financial statements, and the filing contains no financial results.
Joseph M. Rutledge, age 46, appointed Vice President and Chief Accounting Officer on July 14, 2025
Rutledge previously spent 15 years at Eaton Corporation, most recently as vice president and assistant controller since May 2021
Stephen Shamrock ceased to serve as Vice President and Chief Accounting Officer and separated from the company on July 10, 2025
Nordson reported fiscal second-quarter 2025 sales of $683 million, up 5% from a year earlier, with acquisitions adding 8% and organic sales falling 2%. GAAP diluted earnings per share fell to $1.97 from $2.05, while adjusted EPS rose 3% to $2.42. The company forecast third-quarter sales of $710 million to $750 million and adjusted EPS of $2.55 to $2.75.
Sales were $683 million versus $651 million a year earlier; the Atrion acquisition added 8% and organic sales fell 2%.
Net income was $112 million, or $1.97 per diluted share, versus $118 million, or $2.05, a year earlier.
Adjusted EPS was $2.42 versus $2.34; EBITDA was $217 million, or 32% of sales.
Third-quarter guidance: sales of $710 million to $750 million and adjusted EPS of $2.55 to $2.75; management will comment further on a webcast on May 29, 2025 at 8:30 a.m. ET.
Nordson Corporation named Justin Hall as Executive Vice President and segment leader of its Medical and Fluid Solutions (MFS) segment, succeeding Stephen Lovass, who is leaving the company. The filing describes a leadership change in one of the company's three segments and does not include financial results or guidance.
Justin Hall promoted to EVP and MFS segment leader; he joined Nordson in 2006
Stephen Lovass ceased segment leader role on April 28, 2025; he assists until June 1, 2025, then separates from the company
CEO Sundaram Nagarajan said the company expects Hall and the medical leadership team to return the segment to above-market growth
Nordson reported first quarter fiscal 2025 sales of $615 million, down 2.8% from a year earlier, with organic sales down 9%. Diluted EPS was $1.65 versus $1.90, and adjusted diluted EPS was $2.06 versus $2.21. The company guided second quarter sales to $650 million to $690 million and adjusted EPS to $2.30 to $2.50, and said backlog grew about 15% during the quarter.
Q1 sales of $615 million vs. $633 million a year earlier; organic sales fell 9%, with an 8% benefit from acquisitions
GAAP diluted EPS of $1.65 vs. $1.90; adjusted diluted EPS of $2.06 vs. $2.21, a 7% decrease
Q2 fiscal 2025 guidance: sales of $650 million to $690 million and adjusted EPS of $2.30 to $2.50 per diluted share
Backlog rose about $85 million, or 15%, to approximately $670 million; webcast with additional commentary set for February 20, 2025 at 8:30 a.m. ET
Nordson reported fourth-quarter and fiscal 2024 results on December 11, 2024, with fourth-quarter sales up 4% to $744 million and adjusted earnings per diluted share up to $2.78 from $2.71, while GAAP diluted EPS fell to $2.12 from $2.22. The company also forecast fiscal 2025 sales of $2,750 million to $2,870 million and adjusted EPS of $9.70 to $10.50, and said it is taking a conservative view, which shareholders will weigh against fiscal 2024 full-year GAAP EPS of $8.11, down from $8.46.
Q4 2024 sales were $744 million, up 4%, with organic sales down 3% and acquisitions adding 6%.
Full-year fiscal 2024 sales were a record $2.7 billion, up 2%, while GAAP diluted EPS was $8.11 versus $8.46 and adjusted EPS was $9.73 versus $9.85.
Fiscal 2025 guidance: sales of $2,750 million to $2,870 million and adjusted EPS of $9.70 to $10.50 per diluted share.
Management will discuss results and outlook in a webcast on Thursday, December 12, 2024 at 8:30 a.m. Eastern time.
Nordson Corporation completed an underwritten public offering of $600 million in 4.500% notes due 2029 on September 9, 2024. The company intends to use the net proceeds to repay all $500 million of borrowings under its 364-day term loan facility, plus accrued interest, which leaves no loans outstanding under that facility.
Offering: $600 million aggregate principal amount of 4.500% Notes due 2029, completed September 9, 2024
Proceeds intended to repay the $500 million Term Loan Facility in full, plus accrued and unpaid interest
Notes may be redeemed early at 100% of principal plus a make-whole premium before November 15, 2029, and at 100% of principal from that date
Holders may require repurchase at 101% of principal plus accrued interest upon a Change of Control Triggering Event
Nordson reported fiscal third-quarter 2024 sales of $662 million, up 2% from a year earlier, while diluted EPS fell to $2.04 from $2.22 and adjusted EPS fell 6% to $2.41. The company raised its full-year revenue guidance to $2,665 million to $2,705 million to include the Atrion acquisition, but kept its adjusted EPS midpoint unchanged, so shareholders get higher expected sales with profit expectations held steady.
Q3 sales were $662 million, up 2%, including a 4% acquisition benefit and a 1% organic decline.
Diluted EPS was $2.04 versus $2.22 a year earlier; adjusted diluted EPS was $2.41 versus $2.55.
Full-year revenue guidance raised to $2,665 million to $2,705 million; adjusted EPS guidance narrowed to $9.45 to $9.65, midpoint unchanged.
Management will provide further commentary in a webcast on August 22, 2024 at 8:30 a.m. Eastern.
Nordson entered a $500.0 million 364-day delayed draw term loan on June 21, 2024, and a $72.5 million increase to its revolving credit commitments, which brings the revolving facility to $922.5 million. The company plans to use the term loan proceeds in part to fund its previously announced acquisition of Atrion Corporation, so the filing adds debt tied to that deal.
Term Loan Facility: $500.0 million, delayed draw, senior unsecured, matures 364 days after the closing date, which is tied to the Atrion acquisition closing.
Revolving Credit Facility: aggregate commitments increased by $72.5 million to $922.5 million under an Incremental Amendment dated June 21, 2024.
Loans bear interest at a base rate or SOFR plus a margin based on Nordson's leverage ratio; covenants include a leverage ratio and an interest coverage ratio.
Acquisition of Atrion was agreed on May 28, 2024, under a merger agreement in which Atrion becomes a wholly owned subsidiary.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Nordson filing is on SEC EDGAR ↗. 8-K briefs of other companies →